Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: Inhibitor Therapeutics, Inc.
CIK: 1042418
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2013-11-14
Last Filing Date: 2025-03-28
SEC Filings
Start End Frame Filed ACCN Value View
2016-01-01 2016-03-31 CY2015Q1 2016-05-13 0001193125-16-589701 $ 245,353,270 View
2014-01-01 2014-03-31 CY2013Q1 2014-05-12 0001193125-14-194777 $ 18,888,971 View
2014-04-01 2014-06-30 CY2013Q2 2014-08-13 0001193125-14-308476 $ 20,622,065 View
2014-06-25 2014-09-30 CY2013Q3 2014-10-10 0001193125-14-369132 $ 130,115,236 View
2014-01-01 2014-12-31 CY2013 2015-02-13 0001193125-15-050220 $ 95,884,524 View
2015-01-01 2015-03-31 CY2014Q1 2015-05-13 0001193125-15-185035 $ 211,419,937 View
2021-01-01 2021-03-31 CY2020Q1 2021-05-14 0001193125-21-161385 $ 375,527,841 View
2022-01-01 2022-03-31 CY2021Q1I 2022-05-13 0001193125-22-149504 $ 36,438 View
2022-04-01 2022-06-30 CY2021Q2I 2022-08-12 0001193125-22-219960 $ 24,945 View
2022-07-01 2022-09-30 CY2021Q3I 2022-11-14 0001193125-22-284610 $ 53,058 View
2023-04-01 2023-06-30 CY2022Q2 2023-08-11 0001493152-23-027740 $ 12,250 View
2023-07-01 2023-09-30 CY2022Q3 2023-11-13 0001493152-23-040351 $ 1,534 View
2023-01-01 2023-12-31 CY2023 2024-03-29 0001493152-24-011973 $ 17,000 View
2013-07-01 2013-09-30 CY2012Q3 2013-11-14 0001193125-13-442198 $ 18,888,971 View
2015-04-01 2015-06-30 CY2014Q2 2015-08-14 0001193125-15-291734 $ 227,827,263 View
2015-07-01 2015-09-30 CY2014Q3 2015-11-04 0001193125-15-365266 $ 245,353,270 View
2015-01-01 2015-12-31 CY2014 2016-02-01 0001193125-16-446037 $ 232,616,649 View
2016-04-01 2016-06-30 CY2015Q2 2016-08-12 0001193125-16-680021 $ 275,941,869 View
2016-07-02 2016-09-30 CY2015Q3 2016-10-31 0001193125-16-752501 $ 300,353,270 View
2016-01-01 2016-12-31 CY2015 2017-02-17 0001193125-17-048025 $ 288,752,723 View
2017-01-01 2017-03-31 CY2016Q1 2017-05-08 0001193125-17-161842 $ 357,644,397 View
2017-04-01 2017-06-30 CY2016Q2 2017-07-31 0001193125-17-241706 $ 369,481,409 View
2017-07-01 2017-09-30 CY2016Q3 2017-10-31 0001193125-17-326046 $ 369,599,266 View
2017-01-01 2017-12-31 CY2016 2018-02-16 0001193125-18-047834 $ 366,622,107 View
2018-01-01 2018-03-31 CY2017Q1 2018-05-01 0001193125-18-145179 $ 369,615,099 View
2018-04-01 2018-06-30 CY2017Q2 2018-07-23 0001193125-18-223200 $ 369,723,717 View
2018-07-01 2018-09-30 CY2017Q3 2018-11-14 0001193125-18-326293 $ 369,930,943 View
2018-01-01 2018-12-31 CY2017 2019-03-07 0001193125-19-066503 $ 369,812,939 View
2019-01-01 2019-03-31 CY2018Q1 2019-05-09 0001193125-19-142366 $ 370,389,855 View
2019-04-01 2019-06-30 CY2018Q2 2019-08-12 0001193125-19-219046 $ 370,446,185 View
2019-07-01 2019-09-30 CY2018Q3 2019-11-07 0001193125-19-287359 $ 370,446,185 View
2019-01-01 2019-12-31 CY2018 2020-03-30 0001193125-20-090201 $ 370,432,295 View
2020-01-01 2020-03-31 CY2019Q1 2020-05-01 0001193125-20-129857 $ 370,446,185 View
2020-04-01 2020-06-30 CY2019Q2 2020-08-12 0001193125-20-217120 $ 370,446,185 View
2020-07-01 2020-09-30 CY2019Q3 2020-11-16 0001193125-20-294045 $ 373,150,486 View
2020-01-01 2020-12-31 CY2019 2021-03-26 0001193125-21-095516 $ 371,927,734 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-13 0001193125-21-245513 $ 375,876,361 View
2021-07-01 2021-09-30 CY2021Q3 2021-11-12 0001193125-21-327487 $ 376,708,894 View
2021-01-01 2021-12-31 CY2021 2022-03-30 0001193125-22-088832 $ 376,247,777 View
2013-01-01 2013-12-31 CY2013 2014-04-15 0001193125-14-144186 $ 17,940,586 View
2022-01-01 2022-12-31 CY2021 2023-03-31 0001493152-23-010383 $ 189,042 View
2023-01-01 2023-03-31 CY2023Q1 2023-05-15 0001493152-23-016967 $ 411,000 View
2024-01-01 2024-03-31 CY2024Q1 2024-05-13 0001493152-24-018805 $ 270,000 View
2024-01-01 2024-06-30 CY2024Q2I 2024-08-06 0001493152-24-030381 $ 290,000 View
2024-01-01 2024-09-30 CY2024Q3I 2024-11-12 0001493152-24-044473 $ 290,000 View
2024-01-01 2024-12-31 CY2024 2025-03-28 0001641172-25-001190 $ 1 View
SEC Facts By Type
Type Name Description View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Employee Benefits, Current Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Deferred Tax Assets, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. View
us-gaap Deferred Tax Assets, Tax Credit Carryforwards, Research Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. View
us-gaap Cash, FDIC Insured Amount The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. View
us-gaap Cash, Uninsured Amount The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. View
us-gaap Common Stock Dividends, Shares Number of shares of common stock issued as dividends during the period. Excludes stock splits. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Subscriptions Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Convertible Notes Payable Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. View
us-gaap Convertible Preferred Stock, Shares Issued upon Conversion Number of shares issued for each share of convertible preferred stock that is converted. View
us-gaap Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net Amount of net gain (loss) on settlement of other claims for entities in bankruptcy, reported as a reorganization item. View
us-gaap Debtor Reorganization Items, Other Expense (Income) Amount of expense (income) related to reorganization items classified as other. View
us-gaap Deferred Offering Costs Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. View
us-gaap Deferred Revenue Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. View
us-gaap Deferred Revenue, Noncurrent Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, in Process Research and Development Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Deposits Assets, Current Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Dividends Payable, Current Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Dividends, Preferred Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). View
us-gaap Dividends, Preferred Stock, Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock. View
us-gaap Due to Related Parties, Current Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Escrow Deposit The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy. View
us-gaap Gain (Loss) on Sales of Loans, Net The net gain (loss) resulting from a sale of loans, including adjustments to record loans classified as held-for-sale at the lower-of-cost-or-market and fair value adjustments to loan held for investment purposes. View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. View
us-gaap Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Other Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Other Current Assets Amount of increase (decrease) in current assets classified as other. View
us-gaap Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Expense, Related Party Amount of interest expense incurred on a debt or other obligation to related party. View
us-gaap Interest Income (Expense), Net The net amount of operating interest income (expense). View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Interest Payable, Current Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Liabilities Subject to Compromise Total amount of liabilities subject to compromise. View
us-gaap Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities The amount of trade accounts payable included in liabilities subject to compromise. View
us-gaap Liabilities Subject to Compromise, Other Liabilities The amount of other obligations included in liabilities subject to compromise. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Net Income (Loss) Attributable to Parent, Diluted The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions. View
us-gaap Notes Issued The fair value of notes issued in noncash investing and financing activities. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Notes Payable, Related Parties, Current The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Notes Payable to Bank, Current Current portion of the total carrying amount as of the balance sheet date due within one year or the operating cycle, if longer, on all notes payable to banks paid on an installment with long term maturities. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances. View
us-gaap Notes Payable to Bank, Noncurrent The total amount due within more than 12 month, or the operating cycle if longer, on all notes payable to banks paid on an installment. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Other Assets, Current Amount of current assets classified as other. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Noncash Expense Amount of expense or loss included in net income that result in no cash flow, classified as other. View
us-gaap Other Nonoperating Expense Amount of expense related to nonoperating activities, classified as other. View
us-gaap Other Nonoperating Income Amount of income related to nonoperating activities, classified as other. View
us-gaap Other Sundry Liabilities The aggregate carrying amount, as of the balance sheets date, of obligations not otherwise itemized or categorized in the footnotes to the financial statements. View
us-gaap Payments of Dividends Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Proceeds from (Repayments of) Related Party Debt Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Property, Plant and Equipment, Gross Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Purchase price of common stock expressed as a percentage of its fair value. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stockholders' Equity Note, Subscriptions Receivable Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Current Federal, State and Local, Tax Expense (Benefit) Amount of current state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Current Federal Tax Expense (Benefit) Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Current State and Local Tax Expense (Benefit) Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Income Taxes Paid, Net The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. View
us-gaap Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Shares Issued, Price Per Share Per share or per unit amount of equity securities issued. View
us-gaap Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). View
us-gaap Long-term Line of Credit The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. View
us-gaap Preferred Stock Dividends, Income Statement Impact The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. View
us-gaap Related Party Transaction, Due from (to) Related Party, Current Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date within one year where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. View
us-gaap Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation. View
us-gaap Repayments of Other Debt Amount of cash outflow for the payment of debt classified as other. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Stock Issued During Period, Value, Dividend Reinvestment Plan Value of stock issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, Purchase of Assets Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. View
us-gaap Stock Issued During Period, Value, Restricted Stock Award, Gross Aggregate value of stock related to Restricted Stock Awards issued during the period. View
us-gaap Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. View
us-gaap Stock Issued During Period, Value, Stock Dividend Value of stock issued to shareholders as a dividend during the period. View
us-gaap Unrealized Gain (Loss) on Investments Amount of unrealized gain (loss) on investment. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Deferred Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting. View
us-gaap Gain (Loss) Related to Litigation Settlement Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Interest and Other Income The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). View
us-gaap Repayments of Related Party Debt The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. View
us-gaap Stock Issued During Period, Value, Employee Benefit Plan Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. View
us-gaap Number of Reportable Segments Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. View
Chart of Accounts => Accounts
Name View
Notes Issued View
Notes Payable, Current View
Accounts Payable, Current View
Accrued Employee Benefits, Current View
Accrued Liabilities, Current View
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment View
Additional Paid in Capital View
Additional Paid in Capital, Common Stock View
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition View
Adjustments to Additional Paid in Capital, Warrant Issued View
Share-based Payment Arrangement, Expense View
Assets View
Assets, Current View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Cash, FDIC Insured Amount View
Cash, Uninsured Amount View
Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Class of Warrant or Right, Outstanding View
Commitments and Contingencies View
Common Stock Dividends, Shares View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Subscriptions View
Common Stock, Value, Issued View
Convertible Notes Payable View
Convertible Preferred Stock, Shares Issued upon Conversion View
Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net View
Debtor Reorganization Items, Other Expense (Income) View
Deferred Offering Costs View
Deferred Revenue View
Deferred Revenue, Noncurrent View
Deferred Tax Assets, Gross View
Deferred Tax Assets, in Process Research and Development View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Other View
Deferred Tax Assets, Tax Credit Carryforwards, Research View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities View
Deferred Tax Assets, Valuation Allowance View
Deposits Assets, Current View
Depreciation View
Dividends Payable, Current View
Dividends, Preferred Stock View
Dividends, Preferred Stock, Stock View
Due to Related Parties, Current View
Earnings Per Share, Diluted View
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount View
Escrow Deposit View
Gain (Loss) on Sales of Loans, Net View
Gain (Loss) on Extinguishment of Debt View
General and Administrative Expense View
Income Tax Expense (Benefit) View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount View
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount View
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Other Current Assets View
Increase (Decrease) in Other Noncurrent Assets View
Increase (Decrease) in Prepaid Expense and Other Assets View
Increase (Decrease) in Prepaid Expense View
Interest Expense View
Interest Expense, Related Party View
Interest Income (Expense), Net View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Interest Payable, Current View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Liabilities Subject to Compromise View
Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities View
Liabilities Subject to Compromise, Other Liabilities View
Long-term Line of Credit View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Attributable to Parent, Diluted View
Notes Payable to Bank, Current View
Notes Payable to Bank, Noncurrent View
Operating Expenses View
Operating Income (Loss) View
Other Assets, Current View
Other Assets, Noncurrent View
Other Liabilities, Current View
Other Noncash Expense View
Other Nonoperating Expense View
Other Nonoperating Income View
Other Sundry Liabilities View
Payments of Dividends View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Preferred Stock, Value, Issued View
Prepaid Expense and Other Assets, Current View
Prepaid Expense, Current View
Proceeds from Issuance of Common Stock View
Proceeds from Notes Payable View
Proceeds from Related Party Debt View
Proceeds from (Repayments of) Related Party Debt View
Proceeds from Warrant Exercises View
Property, Plant and Equipment, Gross View
Related Party Transaction, Due from (to) Related Party, Current View
Retained Earnings (Accumulated Deficit) View
Revenues View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested View
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity Note, Subscriptions Receivable View
Stock Issued View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Current Federal, State and Local, Tax Expense (Benefit) View
Current Federal Tax Expense (Benefit) View
Current State and Local Tax Expense (Benefit) View
Deferred Tax Liabilities, Net View
Gain (Loss) Related to Litigation Settlement View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Net Income (Loss) Available to Common Stockholders, Basic View
Preferred Stock Dividends, Income Statement Impact View
Interest and Other Income View
Repayments of Related Party Debt View
Stock Issued During Period, Value, Employee Benefit Plan View
Income Taxes Paid, Net View
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Shares Issued, Price Per Share View
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture View
Stock Issued During Period, Shares, New Issues View
Common Stock, Par or Stated Value Per Share View
Earnings Per Share, Basic View
Earnings Per Share, Basic and Diluted View
Net Cash Provided by (Used in) Operating Activities View
Notes Payable, Related Parties, Current View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Repayments of Notes Payable View
Repayments of Other Debt View
Research and Development Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Stock Issued During Period, Shares, Restricted Stock Award, Gross View
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Dividend Reinvestment Plan View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Purchase of Assets View
Stock Issued During Period, Value, Restricted Stock Award, Gross View
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures View
Stock Issued During Period, Value, Stock Dividend View
Unrealized Gain (Loss) on Investments View
Number of Reportable Segments View